or Try an Advanced Search...

    Technical Analysis for 0IRF - Evotec SE

    Grade Last Price % Change Price Change
    F 9.37 1.27% 0.12
    0IRF closed up 1.27 percent on Friday, April 26, 2024, on 57 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical 0IRF trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Below Lower BB Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 1.27%
    Hammer Candlestick Bullish 1.27%
    Lizard Bullish Bullish Day Trade Setup 1.27%
    Gilligan's Island Buy Setup Bullish Swing Setup 1.27%
    Older End-of-Day Signals for 0IRF ...

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    TradingView chart

    Profile

    Evotec SE Description

    Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

    Classification
    Keywords: Health Biotechnology Pain Life Sciences Pharmaceutical Industry Drug Discovery Pharmaceutical Products Infectious Diseases Rare Diseases Pharmaceutical Industry In China Diabetes Respiratory Diseases Fibrosis Inflammation Biotechnology Industry Bristol Myers Squibb Pfizer

    Is 0IRF a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 24.14
    52 Week Low 9.162
    Average Volume 20,566
    200-Day Moving Average 17.76
    50-Day Moving Average 13.37
    20-Day Moving Average 13.21
    10-Day Moving Average 12.28
    Average True Range 0.73
    RSI (14) 25.93
    ADX 29.47
    +DI 15.78
    -DI 49.92
    Chandelier Exit (Long, 3 ATRs) 12.44
    Chandelier Exit (Short, 3 ATRs) 11.35
    Upper Bollinger Bands 16.49
    Lower Bollinger Band 9.92
    Percent B (%b) -0.08
    BandWidth 49.79
    MACD Line -0.83
    MACD Signal Line -0.32
    MACD Histogram -0.5122
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.52
    Resistance 3 (R3) 9.50 9.44 9.49
    Resistance 2 (R2) 9.44 9.40 9.44 9.49
    Resistance 1 (R1) 9.40 9.37 9.42 9.42 9.48
    Pivot Point 9.33 9.33 9.34 9.34 9.33
    Support 1 (S1) 9.30 9.29 9.32 9.32 9.26
    Support 2 (S2) 9.23 9.27 9.24 9.25
    Support 3 (S3) 9.20 9.23 9.24
    Support 4 (S4) 9.22